Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

Nature Medicine

Volumn 10, Issue 11, 2004, Pages 1245-1250

  Cheng, Lihong ^a   Ding, Guoliang ^a   Qin, Qianhong ^a   Huang, Yao ^a   Lewis, William ^b   He, Nu ^a   Evans, Ronald M ^c   Schneider, Michael D ^d   Brako, Florence A ^a   Xiao, Yan ^a   Chen, Yuqing E ^a   Yang, Qinglin ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOWN REGULATION; ENERGY BALANCE; ENERGY RESOURCE; FATTY ACID OXIDATION; GENE DELETION; GENE EXPRESSION; HEART DISEASE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING;

ANALYSIS OF VARIANCE; ANIMALS; CARDIOMYOPATHIES; FATTY ACIDS; GENE DELETION; GENE EXPRESSION REGULATION; GLUCOSE; IMMUNOBLOTTING; IN SITU NICK-END LABELING; MALONYL COENZYME A; MICE; MICE, KNOCKOUT; MULTIENZYME COMPLEXES; MYOCARDIUM; OXIDATION-REDUCTION; PPAR DELTA; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

ANIMALIA; APOGON BRACHYGRAMMUS;

EID: 9144262378     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1116     Document Type: Article

References (26)

1. van der Vusse, G.J., Glatz, J.F., Stam, H.C. & Reneman, R.S. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol. Rev. 72, 881-940 (1992).
2. Vary, T.C., Reibel, D.K. & Neely, J.R. Control of energy metabolism of heart muscle. Annu. Rev. Physiol. 43, 419-430 (1981).
3. Neely, J.R., Rovetto, M.J. & Oram, J.F. Myocardial utilization of carbohydrate and lipids. Prog. Cardiovasc. Dis. 15, 289-329 (1972).
4. Wang, Y.X. et al. Peroxisome proliferator activated receptor δ activates fat metabolism to prevent obesity. Cell 113, 159-170 (2003).
5. Tanaka, T. et al. Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. USA 100, 15924-15929 (2003).
6. Dressel, U. et al. The peroxisome proliferator-activated receptor β/δ agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol. Endocrinol. 17, 2477-2493 (2003).
7. Gilde, A.J. et al. Peroxisome proliferator-activated receptor (PPAR) α and PPARβ/δ, but not PPARγ, modulate the expression of genes involved in cardiac lipid metabolism. Circ. Res. 92, 518-524 (2003).
8. Cheng, L. et al. Peroxisome proliferator-activated receptor δ activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. Biochem. Biophys. Res. Commun. 313, 277-286 (2004).
9. Barak, Y. et al. Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA 99, 303-308 (2002).
10. Peters, J.M. et al. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator- activated receptor β(δ). Mol. Cell Biol. 20, 5119-5128 (2000).
11. Agah, R. et al. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Invest. 100, 169-179 (1997).
12. Gutstein, D.E. et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ. Res. 88, 333-339 (2001).
13. Watanabe, K. et al. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with age-dependent cardiac toxicity. J. Biol. Chem. 275, 22293-22299 (2000).
14. Kersten, S. et al. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J. Clin. Invest. 103, 1489-1498 (1999).
15. Lee, Y. et al. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 46, 408-413 (1997).
16. Chiu, H.C. et al. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107, 813-822 (2001).
17. Yagyu, H. et al. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J. Clin. Invest. 111, 419-426 (2003).
18. Zhou, Y.T. et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. USA 97, 1784-1789 (2000).
19. Regan, T.J. & Weisse, A.B. Diabetic cardiomyopathy. J. Am. Coll. Cardiol. 19, 1165-1166 (1992).
20. Zoneraich, S. & Mollura, J.L. Diabetes and the heart: state of the art in the 1990s. Can. J. Cardiol. 9, 293-299 (1993).
21. Szczepaniak, L.S. et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am. J. Physiol. 276, E977-E989 (1999).
22. Chatham, J.C., Gao, Z.P. & Forder, J.R. Impact of 1 wk of diabetes on the regulation of myocardial carbohydrate and fatty acid oxidation. Am. J. Physiol. 277, E342-E351 (1999).
23. Shindo, Y., Osumi, T. & Hashimoto, T. Effects of administration of di-(2-ethylhexyl)phthalate on rat liver mitochondria. Biochem. Pharmacol. 27, 2683-2688 (1978).
24. King, M.T. & Reiss, P.D. Separation and measurement of short-chain coenzyme-A compounds in rat liver by reversed-phase high-performance liquid chromatography. Anal. Biochem. 146, 173-179 (1985).
25. Saddik, M., Gamble, J., Witters, L.A. & Lopaschuk, G.D. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J. Biol. Chem. 268, 25836-25845 (1993).
26. Coven, D.L. et al. Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise. Am. J. Physiol. Endocrinol. Metab. 285, E629-E636 (2003).